Catalyst Wire Dossier Catalyst Wire Dossier

Vyndaqel

tafamidis · Pfizer
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Vyndaqel, covering 2019-05-03 to 2026-08-27. Get the full timeline:

Most recent: EMA Authorised: Vyndaqel (tafamidis) — Pfizer Europe MA EEIG

See pricing